Menovazin - a drug that has analgesic and local irritant effect.
Release form and composition
Dosage form - alcohol solution for external use: colorless, transparent, with menthol odor (25 ml in glass bottles, in a carton of 108 or 120 bottles; 40 or 50 ml in glass bottles, in a carton of 1, 108 or 120 bottles ).
In 1 ml of solution contains:
- Menthol - 25 mg;
- Procaine - 10 mg;
- Benzocaine - 10 mg.
Auxiliary component - 70% ethanol.
Indications for use
As a local anesthetic, Menovazine is used for arthralgia, myalgia and neuralgia. As an antipruritic drug - for pruritic dermatoses.
- Inflammatory skin diseases at the site of application;
- Violation of the integrity of the skin;
- Hypersensitivity to the components.
Menovazine should be used with caution in pregnant and lactating women, children and adolescents under 18 years of age.
Dosing and Administration
The drug is intended for external use.
The solution should be applied 2-3 times a day to the affected areas or to the skin under the affected area and rub.
The duration of treatment depends on the severity of the therapeutic effect, but should not exceed 3-4 weeks. If necessary, conduct a second course of treatment.
Menovazin is generally well tolerated. In some cases, allergic reactions and contact dermatitis occur. With prolonged treatment may decrease blood pressure, asthenia and dizziness.
Before using Menovazina, you should consult a doctor.
The drug does not adversely affect the speed of psychophysical reactions and the ability to concentrate.
Data on the effect of the drug on the body of pregnant and lactating women are not available.
Information about the interaction of Menovazin with other drugs is missing.
Terms and conditions of storage
Store at a temperature not exceeding 15 ° C in a dark place out of the reach of children.
Shelf life is 2 years.